Literature DB >> 1834187

Liquorpheresis (CSF-filtration): an effective treatment in acute and chronic severe autoimmune polyradiculoneuritis (Guillain-Barré syndrome).

K H Wollinsky1, M Weindler, P J Hülser, P Geiger, N Matzek, H H Mehrkens, H H Kornhuber.   

Abstract

In recent years, plasmapheresis has become a well established treatment of acute and chronic polyradiculoneuritis (Guillain-Barré syndrome, GBS). Nevertheless, there are still non-responders and there are particular risks associated with this treatment. Despite all efforts, the duration of severe forms of Guillain-Barré syndrome is still considerable. Inflammation and demyelination start intrathecally. We therefore used liquorpheresis (cerebrospinal fluid filtration) as a new effective therapeutic approach. Our first patient, severely disabled with acute GBS, artificially ventilated, had undergone plasma exchange without effect. Plasma immunoadsorption led only to transient improvement. After several liquorphereses, the patient recovered completely. In three additional patients with acute and two with chronic GBS an improvement of clinical signs in close temporal relation to liquorpheresis was observed. Twice, liquorpheresis was combined with immunoadsorption of cerebrospinal fluid. Liquorpheresis was well tolerated in all cases. This procedure may be effective by eliminating humoral or cell-bound factors responsible for the onset or/and maintenance of inflammation. Further controlled studies are necessary and are in progress.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1834187     DOI: 10.1007/bf02191143

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  15 in total

Review 1.  Secretory products of macrophages.

Authors:  C F Nathan
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

Review 2.  Management of Guillain-Barré syndrome.

Authors:  R Ferner; M Barnett; R A Hughes
Journal:  Br J Hosp Med       Date:  1987-12

3.  Treatment of acute polyneuropathy by plasma exchange.

Authors:  R P Brettle; M Gross; N J Legg; M Lockwood; C Pallis
Journal:  Lancet       Date:  1978-11-18       Impact factor: 79.321

4.  Treating chronic relapsing Guillain-Barré syndrome by plasma exchange.

Authors:  R L Levy; R Newkirk; J Ochoa
Journal:  Lancet       Date:  1979-08-04       Impact factor: 79.321

5.  Plasmapheresis and acute Guillain-Barré syndrome. The Guillain-Barré syndrome Study Group.

Authors: 
Journal:  Neurology       Date:  1985-08       Impact factor: 9.910

6.  The treatment of chronic relapsing and chronic progressive idiopathic inflammatory polyneuropathy by plasma exchange.

Authors:  M L Gross; P K Thomas
Journal:  J Neurol Sci       Date:  1981-10       Impact factor: 3.181

Review 7.  A critical review of therapies in acute and chronic inflammatory demyelinating polyneuropathies.

Authors:  J D Pollard
Journal:  Muscle Nerve       Date:  1987 Mar-Apr       Impact factor: 3.217

8.  Treatment of chronic relapsing inflammatory polyradiculoneuropathy by plasma exchange.

Authors:  A C Server; J Lefkowith; H Braine; G M McKhann
Journal:  Ann Neurol       Date:  1979-09       Impact factor: 10.422

9.  Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  P J Dyck; J Daube; P O'Brien; A Pineda; P A Low; A J Windebank; C Swanson
Journal:  N Engl J Med       Date:  1986-02-20       Impact factor: 91.245

10.  Guillain-Barré syndrome: activated complement components C3a and C5a in CSF.

Authors:  H P Hartung; C Schwenke; D Bitter-Suermann; K V Toyka
Journal:  Neurology       Date:  1987-06       Impact factor: 9.910

View more
  1 in total

1.  The acute paralysis in Guillain-Barré syndrome is related to a Na+ channel blocking factor in the cerebrospinal fluid.

Authors:  H Brinkmeier; K H Wollinsky; P J Hülser; M J Seewald; H H Mehrkens; H H Kornhuber; R Rüdel
Journal:  Pflugers Arch       Date:  1992-09       Impact factor: 3.657

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.